Browse studies

Find your next paid study

1 recruiting study matching your filters

An Open-Label, Multicenter, Phase 2 Study With Safety Lead-In of Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab in Patients With Angiosarcoma

This is a multicenter, open-label study of Intratumoral Vusolimogene Oderparepvec (VO) to investigate safety and estimate when used in combination with pembrol…

AngiosarcomaAngiosarcoma, Adult

Estimated

~$10 – $7,500

Varun Monga, MBBSNCT06898970